Skip to main content
Fig. 1 | Surgical and Experimental Pathology

Fig. 1

From: Clinical, pathological and prognostic implications of USP22, SIRT1 and E-cadherin expression in papillary thyroid cancer (PTC) and adjacent non-neoplastic tissue

Fig. 1

Immunohistochemical expression of USP22 in papillary thyroid carcinoma (PTC) a High expression in the cytoplasm of poorly differentiated PTC stage IV × 400, b High expression in the cytoplasm of moderately differentiated PTC stage III × 400, c low expression in the cytoplasm of well differentiated follicular variant of PTC stage II× 400, d negative expression in the cytoplasm of well differentiated variant of PTC stage I× 400 e negative expression in adjacent non-neoplastic thyroid follicles × 400

Back to article page

Surgical and Experimental Pathology

ISSN: 2520-8454

Contact us